AG
RCKT icon

Artal Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Artal Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-360,000
Closed -$5.4M – 123
2019
Q2 		$5.4M Sell
360,000
-40,000
-10% -$698K 0.25% 75
2019
Q1 		$7.02M Hold
400,000
– – 0.34% 64
2018
Q4 		$5.93M Hold
400,000
– – 0.3% 64
2018
Q3 		$9.85M Hold
400,000
– – 0.34% 56
2018
Q2 		$7.85M Buy
400,000
+150,000
+60% +$2.84M 0.21% 53
2018
Q1 		$4.69M Buy
+250,000
New +$4.08M 0.07% 72

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return